Pub. Date : 2001 Apr
PMID : 11566012
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | ICOS-Texas Biotechnology is developing the endothelin A (ETA) receptor antagonist, sitaxsentan, for the potential treatment of pulmonary hypertension, congestive heart failure (CHF), chronic obstructive pulmonary disease and subarachnoid hemorrhage [205713], [302200]. | sitaxsentan | inducible T cell costimulator | Homo sapiens |